CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SKAREDOFF, M. N.
Right arrow Articles by DATTA, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SKAREDOFF, M. N.
Right arrow Articles by DATTA, S.

Canadian Journal of Anesthesia, Vol 29, 35-41, Copyright © 1982 by Canadian Anesthesiologists' Society

Hypermagnesaemia and Anaesthetic Management

MICHAEL N. SKAREDOFF 1, EDWARD R. ROAF 1, and SANJAY DATTA 1

1 Harvard Medical School and Department of Anaesthesia, The Brigham and Women's Hospital, Boston, Massachusetts 02115, U.S.A.

The anaesthetic management of a pre-eclamptic parturient who was treated with high doses of magnesium sulphate and who developed hypermagnesaemia before delivery by Caesarean Section, is presented. The pharmacology of magnesium, particularly its effects at the neuromuscular junction, and clinical considerations of magnesium administration are discussed.

Key Words: COMPLICATIONS, pre-eclampsia, hypermagnesaemia • PHARMACOLOGY, magnesium







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the Canadian Anesthesiologists' Society.